ADTX logo

Aditxt, Inc. Common Stock


ADTX: Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes a tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.


Show ADTX Financials

Consumer Interest
SEC Filings

Recent trades of ADTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ADTX's directors and management

Government lobbying spending instances

  • $40,000 Jul 18, 2022 Issue: Health Issues
  • $60,000 Apr 19, 2022 Issue: Health Issues
  • $20,000 Jan 18, 2022 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ADTX in WallStreetBets Daily Discussion


Recent insights relating to ADTX

CNBC Recommendations

Recent picks made for ADTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ADTX

Corporate Flights

Flights by private jets registered to ADTX